CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- 4 Open-market sale CEO and Chairman sold 54,028 shares at an average $37.74 ($2,039,237)
- 4 Open-market sale SVP and General Counsel sold 2,880 shares at $36.03 ($103,766)
- 4 Open-market sale Director sold 2,000,000 shares at $40.00 ($80,000,000)
- 4 Open-market sale Chief Business Development Off sold 417 shares at $40.00 ($16,680)
- 4 Open-market sale Chief People Officer sold 2,000 shares at an average $43.86 ($87,710)
- 4 Open-market sale Chief Scientific Officer sold 33,300 shares at an average $39.58 ($1,317,980)
- 4 Open-market sale Director sold 2,000 shares at an average $43.85 ($87,690)
- 8-K Event Material agreement · Results of operations · Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- S-3ASR Offering Registration Statement
- 4 Open-market sale Chief Financial Officer sold 30,000 shares at an average $46.87 ($1,406,073)
- 4 Open-market sale President sold 15,275 shares at $49.00 ($748,475)
- 4 Open-market sale EVP, Operations & Program Mana sold 17,400 shares at $49.00 ($852,600)
- 4 Open-market sale Director sold 10,000 shares at an average $47.37 ($473,656)
- 4 Open-market sale Chief Medical Officer sold 6,250 shares at an average $47.33 ($295,789)
- 4 Open-market sale Chief Business Development Off sold 6,771 shares at an average $47.34 ($320,540)
- 4 Open-market sale EVP, Operations & Program Mana sold 3,000 shares at an average $47.42 ($142,266)
- 4 Open-market sale Chief Business Development Off sold 417 shares at $47.42 ($19,774)
- 4 Open-market sale Chief Business Development Off sold 417 shares at $47.42 ($19,774)
Page 33 of 42 · 837 filings